Marquette Asset Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-9,436	Closed	-$154K	–	218
2022 Q4	$154K	Sell	9,436 -3,456	-27%	-$56.5K	0.05%	82
2022 Q3	$118K	Sell	12,892 -6,753	-34%	-$61.8K	0.04%	95
2022 Q2	$96K	Buy	+19,645	New	+$96K	0.03%	132